BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Iftikhar Ahmed, Faisal Fayyaz, Moneeb Nasir, Zafar Niaz, Manuele Furnari, Lorna Perry. Extending landscape of volatile metabolites as novel diagnostic biomarkers of inflammatory bowel disease – a reviewScandinavian Journal of Gastroenterology 2016; 51(4): 385 doi: 10.3109/00365521.2015.1105286
2
Seongho Kim, Xinmin Yin, Md Aminul Islam Prodhan, Xiang Zhang, Zichun Zhong, Ikuko Kato. Global Plasma Profiling for Colorectal Cancer-Associated Volatile Organic Compounds: a Proof-of-Principle StudyJournal of Chromatographic Science 2019; 57(5): 385 doi: 10.1093/chromsci/bmz011
3
Elaine Holmes, Ian D. Wilson, John C. Lindon. The Handbook of Metabolic Phenotyping2019; : 1 doi: 10.1016/B978-0-12-812293-8.00001-3
4
Simone Birgit Bayer, Richard Blair Gearry, Lynley Ngaio Drummond. Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal functionCritical Reviews in Food Science and Nutrition 2018; 58(14): 2432 doi: 10.1080/10408398.2017.1327841
5
Iftikhar Ahmed, Rosemary Greenwood, Ben de Lacy Costello, Norman M. Ratcliffe, Chris S. Probert, David L. Boone. An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel SyndromePLoS ONE 2013; 8(3): e58204 doi: 10.1371/journal.pone.0058204
6
Sofie Bosch, Dion S.J. Wintjens, Alfian Wicaksono, Johan Kuijvenhoven, René van der Hulst, Pieter Stokkers, Emma Daulton, Marieke J. Pierik, James A. Covington, Tim G.J. de Meij, Nanne K.H. de Boer. The faecal scent of inflammatory bowel disease: Detection and monitoring based on volatile organic compound analysisDigestive and Liver Disease 2020; 52(7): 745 doi: 10.1016/j.dld.2020.03.007
7
Xiaojun Zhuang, Zhenyi Tian, Mei Luo, Lishou Xiong. Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndromeBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01336-6
8
Bin Feng, Jun-ho La, Erica S. Schwartz, Takahiro Tanaka, Timothy P. McMurray, G. F. Gebhart. Long-term sensitization of mechanosensitive and -insensitive afferents in mice with persistent colorectal hypersensitivityAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 302(7): G676 doi: 10.1152/ajpgi.00490.2011
9
Kannan Ponnusamy, Jung Nam Choi, Jiyoung Kim, Sun-Young Lee, Choong Hwan Lee. Microbial community and metabolomic comparison of irritable bowel syndrome faeces Journal of Medical Microbiology 2011; 60(6): 817 doi: 10.1099/jmm.0.028126-0
10
Dorottya Nagy-Szakal, Dinesh K. Barupal, Bohyun Lee, Xiaoyu Che, Brent L. Williams, Ellie J. R. Kahn, Joy E. Ukaigwe, Lucinda Bateman, Nancy G. Klimas, Anthony L. Komaroff, Susan Levine, Jose G. Montoya, Daniel L. Peterson, Bruce Levin, Mady Hornig, Oliver Fiehn, W. Ian Lipkin. Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomicsScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-28477-9
11
Akira Tokumura. Physiological Significance of Lysophospholipids that Act on the Lumen Side of Mammalian Lower Digestive TractsJOURNAL OF HEALTH SCIENCE 2011; 57(2): 115 doi: 10.1248/jhs.57.115
12
Sarah O'Flaherty, Delphine Saulnier, Bruno Pot, James Versalovic. How can probiotics and prebiotics impact mucosal immunity?Gut Microbes 2010; 1(5): 293 doi: 10.4161/gmic.1.5.12924
13
Susanne Schiffmann, Daniela Hartmann, Sina Fuchs, Kerstin Birod, Nerea Ferreiròs, Yannick Schreiber, Aleksandra Zivkovic, Gerd Geisslinger, Sabine Grösch, Holger Stark. Inhibitors of specific ceramide synthasesBiochimie 2012; 94(2): 558 doi: 10.1016/j.biochi.2011.09.007
14
Xiaojun Zhang, Franky F. K. Choi, Yan Zhou, Feung P. Leung, Shun Tan, Shuhai Lin, Hongxi Xu, Wei Jia, Joseph J. Y. Sung, Zongwei Cai, Zhaoxiang Bian. Metabolite profiling of plasma and urine from rats with TNBS-induced acute colitis using UPLC-ESI-QTOF-MS-based metabonomics - a pilot studyFEBS Journal 2012; 279(13): 2322 doi: 10.1111/j.1742-4658.2012.08612.x
15
Emeran A. Mayer, Tor Savidge, Robert J. Shulman. Brain–Gut Microbiome Interactions and Functional Bowel DisordersGastroenterology 2014; 146(6): 1500 doi: 10.1053/j.gastro.2014.02.037
16
Takaaki Matsufuji, Masanao Kinoshita, Anna Möuts, J. Peter Slotte, Nobuaki Matsumori. Preparation and Membrane Properties of Oxidized Ceramide DerivativesLangmuir 2018; 34(1): 465 doi: 10.1021/acs.langmuir.7b02654
17
Jia-Qian Chen, Yan-Yan Chen, Hui-Juan Tao, Zong-Jin Pu, Xu-Qin Shi, Jing Zhang, Ya-Jie Tan, Shi-Jun Yue, Gui-Sheng Zhou, Er-Xin Shang, Yu-Ping Tang, Jin-Ao Duan. An integrated metabolomics strategy to reveal dose-effect relationship and therapeutic mechanisms of different efficacy of rhubarb in constipation ratsJournal of Pharmaceutical and Biomedical Analysis 2020; 177: 112837 doi: 10.1016/j.jpba.2019.112837
18
Bin Feng, Jun Ho La, Erica S. Schwartz, G. F. Gebhart. Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndromeAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 302(10): G1085 doi: 10.1152/ajpgi.00542.2011
19
Anna Caretti, Alessandra Bragonzi, Marcella Facchini, Ida De Fino, Camilla Riva, Paolo Gasco, Claudia Musicanti, Josefina Casas, Gemma Fabriàs, Riccardo Ghidoni, Paola Signorelli. Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosisBiochimica et Biophysica Acta (BBA) - General Subjects 2014; 1840(1): 586 doi: 10.1016/j.bbagen.2013.10.018
20
Iftikhar Ahmed, Zafar Niaz, Frederick Ewbank, Danyal Akarca, Richard Felwick, Manuele Furnari. Sniffing out causes of gastrointestinal disorders: a review of volatile metabolomic biomarkersBiomarkers in Medicine 2018; 12(10): 1139 doi: 10.2217/bmm-2018-0074
21
Sabine Grösch, Susanne Schiffmann, Gerd Geisslinger. Chain length-specific properties of ceramidesProgress in Lipid Research 2012; 51(1): 50 doi: 10.1016/j.plipres.2011.11.001
22
Aihua Zhang, Hui Sun, Ping Wang, Ying Han, Xijun Wang. Modern analytical techniques in metabolomics analysisThe Analyst 2012; 137(2): 293 doi: 10.1039/C1AN15605E
23
Lufang Chen, Keying Xu, Qifeng Gui, Yue Chen, Deying Chen, Yunmei Yang. Probiotic pre-administration reduces mortality in a mouse model of cecal ligation and puncture-induced sepsisExperimental and Therapeutic Medicine 2016; 12(3): 1836 doi: 10.3892/etm.2016.3534
24
Martin F. Almstetter, Peter J. Oefner, Katja Dettmer. Comprehensive two-dimensional gas chromatography in metabolomicsAnalytical and Bioanalytical Chemistry 2012; 402(6): 1993 doi: 10.1007/s00216-011-5630-y
25
Natalia Zeber-Lubecka, Maria Kulecka, Filip Ambrozkiewicz, Agnieszka Paziewska, Krzysztof Goryca, Jakub Karczmarski, Tymon Rubel, Wojciech Wojtowicz, Piotr Mlynarz, Lukasz Marczak, Roman Tomecki, Michal Mikula, Jerzy Ostrowski. Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolomeGut Microbes 2016; 7(5): 397 doi: 10.1080/19490976.2016.1215805
26
Antonella Orlando, Valeria Tutino, Maria Notarnicola, Giuseppe Riezzo, Michele Linsalata, Caterina Clemente, Laura Prospero, Manuela Martulli, Benedetta D’Attoma, Valentina De Nunzio, Francesco Russo. Improved Symptom Profiles and Minimal Inflammation in IBS-D Patients Undergoing a Long-Term Low-FODMAP Diet: A Lipidomic PerspectiveNutrients 2020; 12(6): 1652 doi: 10.3390/nu12061652
27
Xijun Wang, Hui Sun, Aihua Zhang, Ping Wang, Ying Han. Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studiesJournal of Separation Science 2011; 34(24): 3451 doi: 10.1002/jssc.201100333
28
Kamesh Gupta, Harparam Singh Ghuman, Shivani Vijay Handa. Review of Rifaximin: Latest Treatment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical ProfileClinical Medicine Insights: Gastroenterology 2017; 10: 117955221772890 doi: 10.1177/1179552217728905
29
M. Pimentel. Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoeaAlimentary Pharmacology & Therapeutics 2016; 43: 37 doi: 10.1111/apt.13437